Table 2 Clinical and traditional risk factors in patients with and without recurrent CVEs

Age, years

62.58 ± 9.17

58.25 ± 10.50

< 0.001

Male, n (%)

115 (75.2)

1559 (73.2)

0.637

Body mass index, kg/m²

25.85 ± 3.09

26.39 ± 3.15

0.042

BMI < 25 kg/m2

70 (45.9)

718 (33.7)

0.003

SBP, mmHg

127 ± 18

128 ± 17

0.645

SBP < 130 mmHg

78 (51.2)

1057 (49.6)

0.785

DBP, mmHg

76 ± 10

78 ± 16

0.130

DBP < 80 mmHg

72 (47.3)

889 (41.7)

0.231

Heart rate, bpm

71 ± 10

71 ± 10

0.761

Biochemical parameters

 FBG, mmol/L

7.12 ± 2.43

7.24 ± 2.31

0.526

 FBG 4.4 ~ 6.5 mmol/L

60 (38.9)

886 (41.6)

0.548

 HbA1c,  %

7.53 ± 1.37

7.38 ± 1.25

0.150

 HbA1c < 7.0%

74 (48.4)

1072 (50.3)

0.932

 TC, mmol/L

4.03 ± 1.08

4.08 ± 1.19

0.618

 HDL-C, mmol/L

0.99 ± 0.26

1.01 ± 0.27

0.325

 LDL-C, mmol/L

2.44 ± 0.93

2.45 ± 0.97

0.942

 LDL-C < 1.4 mmol/L

16 (10.6)

232 (10.9)

0.907

 TG, mmol/L

1.54 (1.17–2.12)

1.56 (1.17–2.20)

0.502

 Lp(a), mg/dL

20.44 (10.01–43.96)

14.71 (6.43–34.16)

0.002

 ApoAI, g/L

1.29 ± 0.30

1.31 ± 0.30

0.407

 ApoB, g/L

0.91 ± 0.30

0.92 ± 0.30

0.746